VC  Red Abbey Venture Partners

     Office Locations:

10751 Falls Road, Suite 300
Baltimore, MD 21093
Phone: 410-494-4230



  • Early



  • Life Sciences & Healthcare



    Red Abbey Venture Partners was founded in 2004 and has invested in 14 privately-held and 9 publicly-traded life science companies. Red Abbey Venture Partners is the second generation of a life sciences investment program that Frank A. Bonsal, Jr. and Philip Goelet, PhD began in 1997 with an investment in RiboTargets Holdings. The Partnership's primary investment objective is to generate superior, risk-adjusted returns by investing in high-quality life sciences companies that are developing novel therapeutics and other products based on distinctive technologies. The firm expects to capitalize on the advances in molecular biology, drug discovery and medical treatment that have permanently changed the treatment and management of disease. Red Abbey has a select group of family offices and individual investors who have committed $50 million to its fund.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Frank A. Bonsal, Jr. Founding Member and Investment Committee
    Mark Adler MD Advisor
    Matt Zuga Investment Committee
    Philip Goelet PhD Founding Member and Investment Committee


    Portfolio companies include:


    Recent News: